Skip to content

Insider · CIK 0001977817

Agosti Marcello Pignagnoli

officer

Files at TAK (TAKEDA PHARMACEUTICAL CO LTD). First filing Aug 12, 2026, latest Aug 12, 2026.

In brief

Agosti Marcello Pignagnoli files SEC Form 4 as officer at TAK (TAKEDA PHARMACEUTICAL CO LTD). Since Aug 12, 2026, Agosti Marcello Pignagnoli has reported 0 open-market buys worth $0 and 1 open-market sell worth $393k, the latest filed on Aug 12, 2026.

A track record needs three past buys with six months of prices behind them; Agosti Marcello Pignagnoli has 0, so none is measured yet.

The newest scored trade: sold $393k of TAK on Aug 10, 2026, filed Aug 12, 2026, scored 51 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $393k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $393k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TAK: TAKEDA PHARMACEUTICAL CO LTD

TAKOct 12, 2026 · close 18.68

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
51Moderate
TAKsell 13
TAKEDA PHARMACEUTICAL CO LTD
$393k
22,957 shares
-11%+33% from low-7% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jul 13, 2026 TAK
Takeda Pharmaceutical Company Limited
24,887
0.02% of outstanding
$417kJul 13, 2026none
Jul 9, 2025 TAK
Takeda Pharmaceutical Company Limited
18,622
0.02% of outstanding
$287kJul 9, 2025none

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 10, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
SOpen-market sale
American Depositary Shares
-22,957$17.10$393k176,977Aug 12, 2026
Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AGrant or award
American Depositary Shares
+27,586$0.00$0199,934Jul 6, 2026
Apr 27, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AGrant or award
American Depositary Shares
+27,740$0.00$0172,348Apr 28, 2026

Questions about Agosti Marcello Pignagnoli

Answered from the filings on this page, as of the latest one.

Is Agosti Marcello Pignagnoli buying or selling?

In the last 12 months Agosti Marcello Pignagnoli reported 0 open-market buys worth $0 and 1 open-market sell worth $393k on SEC Form 4; the latest was sold $393k of TAK on Aug 10, 2026. Grants, option exercises and tax withholding are not counted.

How did Agosti Marcello Pignagnoli's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Agosti Marcello Pignagnoli has 0.

Where does Agosti Marcello Pignagnoli file Form 4?

Agosti Marcello Pignagnoli has filed Form 4 at TAK (TAKEDA PHARMACEUTICAL CO LTD) as Head, Strat. & Port. Dev. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Agosti Marcello Pignagnoli: insider trades and track record | InsiderTell